Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Ppublish 119 citations
PubMed: 33690918 DOI: 10.1111/prd.12368
Maintaining homeostatic control of periodontal bone tissue.
Periodontol 2000 86(1):157-187
Authors: Jessica D Hathaway-Schrader, Chad M Novince
Affiliations
- Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Abstract
Alveolar bone is a unique osseous tissue due to the proximity of dental plaque biofilms. Periodontal health and homeostasis are mediated by a balanced host immune response to these polymicrobial biofilms. Dysbiotic shifts within dental plaque biofilms can drive a proinflammatory immune response state in the periodontal epithelial and gingival connective tissues, which leads to paracrine signaling to subjacent bone cells. Sustained chronic periodontal inflammation disrupts "coupled" osteoclast-osteoblast actions, which ultimately result in alveolar bone destruction. This chapter will provide an overview of alveolar bone physiology and will highlight why the oral microbiota is a critical regulator of alveolar bone remodeling. The ecology of dental plaque biofilms will be discussed in the context that periodontitis is a polymicrobial disruption of host homeostasis. The pathogenesis of periodontal bone loss will be explained from both a historical and current perspective, providing the opportunity to revisit the role of fibrosis in alveolar bone destruction. Periodontal immune cell interactions with bone cells will be reviewed based on our current understanding of osteoimmunological mechanisms influencing alveolar bone remodeling. Lastly, probiotic and prebiotic interventions in the oral microbiota will be evaluated as potential noninvasive therapies to support alveolar bone homeostasis and prevent periodontal bone loss.
MeSH
Bone Remodeling, Homeostasis, Periodontal Diseases, Microbiota, Biofilms, Cells, Dental Plaque, Tissues, Periodontics, Alveolar Bone Loss
Cited by
- Antimicrobial-induced oral dysbiosis exacerbates naturally occurring alveolar bone loss. FASEB J, 2021
- Quebecol Shows Potential to Alleviate Periodontal Tissue Damage and Promote Bone Formation in Models. ACS Omega, 2021
- Enamel matrix derivative as adjunctive to non-surgical periodontal therapy: a systematic review and meta-analysis of randomized controlled trials. Clin Oral Investig, 2022
- Detailed Correlation between Central Incisor Movement and Alveolar Bone Resorption in Adults with Orthodontic Premolar Extraction Treatment: A Retrospective Cohort CBCT Study. J Clin Med, 2022
- Customized Hydrogel System for the Spatiotemporal Sequential Treatment of Periodontitis Propelled by ZEB1. Adv Sci (Weinh), 2025
- Locally Secreted Semaphorin 4D Is Engaged in Both Pathogenic Bone Resorption and Retarded Bone Regeneration in a Ligature-Induced Mouse Model of Periodontitis. Int J Mol Sci, 2022
- METTL3 promotes osteoblast ribosome biogenesis and alleviates periodontitis. Clin Epigenetics, 2024
- Oral microbiota-host interaction: the chief culprit of alveolar bone resorption. Front Immunol, 2024
- Involvement of the Notch signaling system in alveolar bone resorption. Jpn Dent Sci Rev, 2023
- Dexamethasone-loaded zeolitic imidazolate frameworks nanocomposite hydrogel with antibacterial and anti-inflammatory effects for periodontitis treatment. Mater Today Bio, 2022
- Immunomodulatory IL-23 receptor antagonist peptide nanocoatings for implant soft tissue healing. Dent Mater, 2023
- Highly hydrophilic and dispersed TiOÂ nano-system with enhanced photocatalytic antibacterial activities and accelerated tissue regeneration under visible light. J Nanobiotechnology, 2023
- Commensal oral microbiota induces osteoimmunomodulatory effects separate from systemic microbiome in mice. JCI Insight, 2022
- Insights into periodontal disease: comparative analysis of animal models. Front Dent Med, 2025
- Innovative biomaterials for the treatment of periodontal disease. Front Dent Med, 2023
- Stiffness-tuned and ROS-sensitive hydrogel incorporating complement C5a receptor antagonist modulates antibacterial activity of macrophages for periodontitis treatment. Bioact Mater, 2023
- mTOR Signaling in the Regulation of CD4+ T Cell Subsets in Periodontal Diseases. Front Immunol, 2022
- AFF4 regulates osteogenic potential of human periodontal ligament stem cells via mTOR-ULK1-autophagy axis. Cell Prolif, 2024
- Beneficial effects of non-invasive physical plasma on human periodontal ligament cells . Front Med (Lausanne), 2024
- Ferroptosis in periodontitis: mechanisms, impacts, and systemic connections. Cell Death Discov, 2025